Article Details
Retrieved on: 2018-10-07 06:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Sofinnova Ventures</b> Inc bought a new position in Syndax Pharmaceuticals during the 1st quarter worth $173,000. Rhumbline Advisers bought a new ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here